-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Maintains Buy on Icecure Medical, Lowers Price Target to $1

Benzinga·05/14/2026 20:43:55
Listen to the news
Maxim Group analyst Anthony Vendetti maintains Icecure Medical (NASDAQ:ICCM) with a Buy and lowers the price target from $3 to $1.